Connection

Yaokai Chen to Antiviral Agents

This is a "connection" page, showing publications Yaokai Chen has written about Antiviral Agents.
Connection Strength

0.173
  1. Potential therapeutic options for coronavirus disease 2019: using knowledge of past outbreaks to guide future treatment. Chin Med J (Engl). 2020 06 05; 133(11):1350-1352.
    View in: PubMed
    Score: 0.082
  2. Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol. Chin Med J (Engl). 2020 May 05; 133(9):1132-1134.
    View in: PubMed
    Score: 0.081
  3. The efficacy assessment of convalescent plasma therapy for COVID-19 patients: a multi-center case series. Signal Transduct Target Ther. 2020 10 06; 5(1):219.
    View in: PubMed
    Score: 0.005
  4. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020 06; 26(6):845-848.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.